stock logo

63% Buy

Gland Pharma Share Price

GLAND

₹1,823.20+₹7.20 (0.40%) TodayLast updated on 24 Jun, 2024 | 03:55 PM IST
₹1,788.95₹1,826.95
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹30,412 Crs

Open

₹1,800.00

Close

₹1,816.00

Circuit range

₹2,179.20 - ₹1,452.80

Day range

₹1,788.95 - ₹1,826.95

Year range

₹971.00 - ₹2,194.00

Volume

3,90,829

Avg. traded

₹1,814.95

Revenue (12m)

₹5,665 Crs

Gland PharmaGland Pharma Limited is an India-based generic injectables manufacturer. The Company specializes in sterile injectables, oncology, and ophthalmic, with a specific focus on complex injectables, NCE-1s (New Chemical Entities), First-to-File products, and 505(b)(2) filings. The Company functions primarily on a business-to-business (B2B) model and has a record in pharmaceutical research and development, manufacturing, and marketing of complex injectables. The Company offers a range of delivery systems, including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags, and drops. It is also in the process of including new delivery systems such as pens and cartridges into its product portfolio. Its key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Its therapeutic products categories include Anti Malarials, Anti-Infectives, Anti-Neoplastics, Gynaecological, Hormones, and others.

Gland Pharma Key indicators

arrow

52 week high

₹2,194.00

52 week low

₹971.00

P/E ratio

39.37

P/B ratio

3.49

ROE

10.28%

ROCE

13.97%

Dividend yield

1.09%

Debt/Equity ratio

EPS

47.11

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

63%

Hold

12%

Sell

25%

This analysis is based on the reviews of 16 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

34.81%

Net profit margin

21.45%

ROE

10.28%

ROA

9.34%

ROCE

13.97%

Learn more

Gland Pharma Shareholder returns

arrow

1 day

-0.81%

1 week

-2.14%

1 month

+0.84%

3 months

+3.59%

1 year

+80.45%

3 years

-40.82%

5 years

-0.20%

Gland Pharma Share Price history

arrow
DayOpenCloseDay’s change
Fri, Jun 21 2024
₹1,825.30
₹1,816.00
-0.81%
Thu, Jun 20 2024
₹1,837.00
₹1,830.75
+0.14%
Wed, Jun 19 2024
₹1,869.95
₹1,828.10
-0.63%
Tue, Jun 18 2024
₹1,842.90
₹1,839.65
-0.34%
Fri, Jun 14 2024
₹1,874.35
₹1,845.95
-0.53%
Thu, Jun 13 2024
₹1,892.50
₹1,855.80
-0.96%
Wed, Jun 12 2024
₹1,878.00
₹1,873.75
-0.10%
Tue, Jun 11 2024
₹1,890.00
₹1,875.65
-0.62%

Shareholding info

arrow

Promoters (57.86%)

Mutual Funds (23.01%)

Retail and other (13.32%)

Foreign institutions-FII (3.59%)

Other domestic institutions (2.22%)

Promoters

Learn more

Frequently asked questions